Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate.
A 32-year infertile Japanese woman suffered from endometrial cancer, which was treated with repeated endometrial curettage and medroxyprogesterone acetate for 6 months. The patient then became pregnant and was delivered of a live-born male infant at 37 weeks gestation by cesarean section for placenta previa. At cesarean section there were no abnormal findings in the uterine cavity or other pelvic organs.
Niwa
K
K
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Yokoyama
Y
Y
Tanaka
T
T
Murase
T
T
Morishita
S
S
Itoh
M
M
Itoh
N
N
Shimokawa
K
K
Tamaya
T
T
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000328:Adult; D002585:Cesarean Section; D003131:Combined Modality Therapy; D004107:Dilatation and Curettage; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D010923:Placenta Previa / Q000601:surgery; D011247:Pregnancy; D011256:Pregnancy Outcome
D017258:Medroxyprogesterone Acetate